SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VICL (Vical Labs)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Yegerlehner who wrote (190)4/28/1997 6:10:00 PM
From: icanpickem   of 1972
 
Hi Jim----If you look at the carnage in the biotech stocks in general you will not feel that Vical is being singled out. The average stock in this group is down approximately 40%. All you have to look at are the two closed end funds (HQL and HQH) which are listed on the NYSE to get a good picture of the group. With reference to VICL in particular there is no evidence of any negative news to account for the decline. Frankly, I think it is very close to the bottom having dropped 50% from its high last year although it appears that they have been making much scientific progress including 2 patents which may prove to quite valuable. Also, please note that in the absence of institutional interest the market makers will maintain minimum inventories. When the time comes the initial upside movement will come without warning and be quite dramatic. Nobody can pick the bottom but if I were a long term investor I would be buying now. LOTS OF LUCK||||||||
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News